Back to User profile » Dr Suayib Yalcin
Papers published by Dr Suayib Yalcin:
Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
Kahraman S, Yalcin S
OncoTargets and Therapy 2021, 14:4149-4162
Published Date: 13 July 2021
Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO
Journal of Hepatocellular Carcinoma 2020, 7:143-153
Published Date: 16 September 2020
Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma
Yalcin S, Lacin S
Cancer Management and Research 2019, 11:7779-7785
Published Date: 16 August 2019
A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study
Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E
OncoTargets and Therapy 2018, 11:1223-1228
Published Date: 5 March 2018
Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors
Yıldız Y, Sokmensuer C, Yalcin S
OncoTargets and Therapy 2016, 9:5809-5817
Published Date: 22 September 2016
A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer
Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S
OncoTargets and Therapy 2016, 9:4815-4820
Published Date: 3 August 2016
Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen
Lacin S, Esin E, Karakas Y, Yalcin S
OncoTargets and Therapy 2015, 8:1039-1042
Published Date: 13 May 2015
Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population
Benekli M, Yalcin S, Ozkan M, Elkiran ET, Sevinc A, Cabuk D, Coskun HS, Oksuzoglu B, Bayar B, Akbulat A, Ozet A
OncoTargets and Therapy 2015, 8:1-5
Published Date: 15 December 2014
Neuropathic cancer pain: What we are dealing with? How to manage it?
Esin E, Yalcin S
OncoTargets and Therapy 2014, 7:599-618
Published Date: 17 April 2014
A review of the use of somatostatin analogs in oncology
Keskin O, Yalcin S
OncoTargets and Therapy 2013, 6:471-483
Published Date: 26 April 2013